Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Oct. 31, 2020 $ 242,000 $ 200,355,000 $ (191,836,000) $ 8,761,000 $ (497,000) $ 8,264,000
Beginning balance, shares at Oct. 31, 2020 24,248,695          
Stock option compensation to employees and directors 1,756,000 1,756,000 1,756,000
Stock options and warrants issued to consultants 282,000 282,000 282,000
Common stock issued pursuant to employee stock purchase plan 3,000 3,000 3,000
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Net loss (4,607,000) (4,607,000) (62,000) (4,669,000)
Common stock issued upon exercise of stock options $ 1,000 292,000 293,000 293,000
Common stock issued upon exercise of stock options, shares 107,451          
Common stock issued in a public offering, net of offering expenses of $2,208 $ 44,000 20,248,000 20,292,000 20,292,000
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Common stock issued in at-the-market offering, net of offering expenses of $341 $ 28,000 10,806,000 10,834,000 10,834,000
Common stock issued in at-the-market offering, net of offering expenses, shares 2,806,410          
Ending balance, value at Apr. 30, 2021 $ 315,000 233,742,000 (196,443,000) 37,614,000 (559,000) 37,055,000
Ending balance, shares at Apr. 30, 2021 31,449,905          
Beginning balance, value at Jan. 31, 2021 $ 262,000 207,382,000 (194,044,000) 13,600,000 (521,000) 13,079,000
Beginning balance, shares at Jan. 31, 2021 26,179,122          
Stock option compensation to employees and directors 881,000 881,000 881,000
Stock options and warrants issued to consultants 170,000 170,000 170,000
Common stock issued pursuant to employee stock purchase plan 3,000 3,000 3,000
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Net loss (2,399,000) (2,399,000) (38,000) (2,437,000)
Common stock issued upon exercise of stock options $ 1,000 189,000 190,000 190,000
Common stock issued upon exercise of stock options, shares 77,571          
Common stock issued in a public offering, net of offering expenses of $2,208 $ 43,000 20,249,000 20,292,000 20,292,000
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Common stock issued in at-the-market offering, net of offering expenses of $341 $ 9,000 4,868,000 4,877,000 4,877,000
Common stock issued in at-the-market offering, net of offering expenses, shares 905,863          
Ending balance, value at Apr. 30, 2021 $ 315,000 233,742,000 (196,443,000) 37,614,000 (559,000) 37,055,000
Ending balance, shares at Apr. 30, 2021 31,449,905          
Beginning balance, value at Oct. 31, 2021 $ 301,000 239,927,000 (204,790,000) 35,438,000 (671,000) 34,767,000
Beginning balance, shares at Oct. 31, 2021 30,050,894          
Stock option compensation to employees and directors 3,598,000 3,598,000 3,598,000
Stock options and warrants issued to consultants 437,000 437,000 437,000
Common stock issued to consultants $ 1,000 63,000 64,000 64,000
Common stock issued to consultants, shares 20,000          
Common stock issued pursuant to employee stock purchase plan 7,000 7,000 7,000
Common stock issued pursuant to employee stock purchase plan, shares 2,389          
Net loss (7,373,000) (7,373,000) (94,000) (7,467,000)
Common stock issued upon exercise of stock options and warrants
Common stock issued upon exercise of stock options and warrants, shares 81,425          
Ending balance, value at Apr. 30, 2022 $ 302,000 244,032,000 (212,163,000) 32,171,000 (765,000) 31,406,000
Ending balance, shares at Apr. 30, 2022 30,154,708          
Beginning balance, value at Jan. 31, 2022 $ 301,000 242,281,000 (208,619,000) 33,963,000 (721,000) 33,242,000
Beginning balance, shares at Jan. 31, 2022 30,132,319          
Stock option compensation to employees and directors 1,462,000 1,462,000 1,462,000
Stock options and warrants issued to consultants 219,000 219,000 219,000
Common stock issued to consultants $ 1,000 63,000 64,000 64,000
Common stock issued to consultants, shares 20,000          
Common stock issued pursuant to employee stock purchase plan 7,000 7,000 7,000
Common stock issued pursuant to employee stock purchase plan, shares 2,389          
Net loss (3,544,000) (3,544,000) (44,000) (3,588,000)
Ending balance, value at Apr. 30, 2022 $ 302,000 $ 244,032,000 $ (212,163,000) $ 32,171,000 $ (765,000) $ 31,406,000
Ending balance, shares at Apr. 30, 2022 30,154,708